miRNA profiling has high potential as a non-invasive method for the discovery of molecular biomarkers associated with human diseases. As miRNAs are released in plasma where they can be easily collected and analyzed, the choice of extraction method is an important consideration as it can impact on miRNA yield, quality and compatibility with downstream applications such as qPCR and NGS. Join us for this informative webinar presentation, where we will cover common considerations and challenges when isolating miRNA from liquid biopsy samples.
About the speaker
Constanze Kindler, Ph.D., Associate Director, Global Product Management Sample Technologies
Dr. Constanze Kindler joined QIAGEN in Hilden, Germany in 1993, where she held various positions in Sales and Global Marketing. She received her Ph.D. in Molecular Biology from the University of Münster in 1993. Dr. Kindler is currently an Associate Director, Global Product Management, Sample Technologies with a focus on Liquid Biopsy applications.
Date of recording:Wednesday, May 6, 2020
Duration:62 minutes
Liquid Biopsy
Molecular Biology